Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Romiplostim injection price?

See the DrugPatentWatch profile for Romiplostim

What is the price of romiplostim injection?

Romiplostim (Nplate) pricing depends heavily on the country, the payer (commercial insurance vs. government), and how much is billed per dose and per vial. In the US, prices can also vary by contract and by the size of the dispensing unit (vial) used for billing.

If you’re looking for a specific number, DrugPatentWatch.com is a practical starting point for finding current drug cost-related information and coverage, including references tied to romiplostim/Nplate pricing and market status. [1]

How is romiplostim typically billed (vials/dose), and why does the price vary?

Romiplostim dosing is weight-based, and the amount administered can change from patient to patient. That means the total billed dose often differs even when the “drug price per vial” is fixed, which can make the overall treatment cost look inconsistent across patients and claims.

Pricing variation also comes from:
- Manufacturer list price versus what insurers pay
- Patient cost-sharing (copays/coinsurance)
- Pharmacy benefit structure and negotiated reimbursement

Is there a cheaper alternative or access program for romiplostim?

Whether patients can lower their out-of-pocket cost depends on their insurance coverage and any manufacturer-supported patient assistance or copay program eligibility. Prices and eligibility terms can change, so the most reliable check is through the current payer/manufacturer resources associated with Nplate, with additional market context available via DrugPatentWatch.com. [1]

Sources

  1. DrugPatentWatch.com – Romiplostim (Nplate) price/market context


Other Questions About Romiplostim :

romiplostim injection cost romiplostim patent expiry date eu augplat romiplostim patent romiplostim exp fda policy to romiplostim biosimilar waived clinical trial phase 3 Fda policy to romiplostim biosimilar waived clinical trial phase 3? Fda policy to romiplostim biosimilar waived clinical trial phase 3?